A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells

A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells
复制标题

DOI:
10.1038/onc.2009.22
复制
发表时间:
2009-04-16
期刊:
影响因子:
8
通讯作者:
Watson, R. J.
Watson, R. J.
中科院分区:
医学1区
文献类型:
--
作者:
Knight, A. S.;Notaridou, M.;Watson, R. J.

文献摘要

被引文献

相似文献

最近发现,细胞周期基因的转录受一个名为LINC的核心复合体的调控,该复合体从G(0)-G(1)中与p130或p107口袋蛋白和E2F4的转录抑制复合体切换到S-G(2)中包含B-Myb的转录活性复合体。我们研究了LINC在F9胚胎癌细胞中的功能,F9胚胎癌细胞的特点是极短的G(1)期导致了快速的细胞周期。我们发现在F9细胞中抑制LINC成分LIN-9的表达会导致有丝分裂停滞,我们已经使用这个系统来筛选转录靶标。在这些细胞中,B-Myb存在于与LIN-9和其他几种LINC成分的复合体中,但除非F9细胞分化,否则口袋蛋白不与LINC结合。Cyclin B1、Survivin等G(2)/M基因转录均需要LIN-9和B-Myb。此外,B-Myb通过多个Myb结合位点将Lin-9募集到Survivin启动子上。在缺乏G(1)/S检查点的细胞中,B-Myb/LINC复合体在有丝分裂过程中是至关重要的,这一证明对未分化的胚胎细胞和口袋蛋白功能受损的癌症都有意义。
It has recently been discovered that cell-cycle gene transcription is regulated by a core complex named LINC that switches from a transcriptionally repressive complex in G(0)-G(1) with the p130 or p107 pocket proteins and E2F4 to a transcriptionally active complex in S-G(2) containing B-Myb. We have studied the function of LINC in F9 embryonal carcinoma cells, which are distinguished by a rapid cell cycle resulting from an extremely short G(1) phase. We show that suppressing expression of the LINC component, Lin-9, in F9 cells causes arrest in mitosis, and we have used this system to screen for transcriptional targets. In these cells, B-Myb was found in complexes with Lin-9 and several other LINC constituents, however, the pocket proteins did not associate with LINC unless F9 cells were differentiated. Lin-9 and B-Myb were both required for transcription of G(2)/M genes such as Cyclin B1 and Survivin. Moreover, B-Myb was demonstrated to recruit Lin-9 to the Survivin promoter through multiple Myb-binding sites. The demonstration that a B-Myb/LINC complex is vital for progression through mitosis in cells lacking a G(1)/S checkpoint has implications for both undifferentiated embryonal cells and for cancers in which pocket protein function is compromised.